Bortezomib Injection Clinical Trials

3 actively recruiting trials

Also known as: Velcade

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

Zhejiang University1
Peking Union Medical College Hospital1
AHS Cancer Control Alberta1

Indications

Cancer3
Solitary Plasmacytoma1
Myeloma1
Myeloma, Multiple1
Pancreas Cancer1

Other3 trials

A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment

Phase 2

Bortezomib Combined with PD-1 MAb and MFOLFIRINOX for Metastatic Pancreatic Cancer

Phase 1/2

Chemotherapy Combined With Radiotherapy Versus Radiotherapy Alone for Solitary Plasmacytoma

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.